Clotting protein may be link to heart disease

October 01, 2000

DALLAS, Oct. 3 - A little known clotting protein called fibrinogen may be the missing link between heart disease risk factors, such as smoking and high cholesterol, and heart attacks, according to a study in today's Circulation: Journal of the American Heart Association.

Fibrinogen, a protein produced in the liver, has a pivotal role in the formation of blood clots. A number of factors -- particularly cigarette smoking - increase fibrinogen levels. Higher levels are also seen with advancing age, obesity, physical inactivity and diabetes. Elevated cholesterol is also associated with high fibrinogen, and genetic factors play a role as well.

When subjects in a prior study were divided into three groups, participants with the highest fibrinogen levels were shown to have a 2.3-fold greater risk of coronary disease and heart attack than those in the lowest third.

Here, researchers used a newly developed test called FIF (Functional Intact Fibrinogen) to check fibrinogen levels in 2,632 participants in the Framingham Offspring Study - a continuation of the famed Framingham Heart Study begun more than 50 years ago.

"We not only found fibrinogen levels to be higher in people with heart disease but it also seems to be a common pathway by which other risk factors cause heart disease," says one of the study's authors Geoffrey H. Tofler, M.D. a former associate professor at Harvard Medical School, now a professor of cardiology at Royal North Shore Hospital in Sydney, Australia.

Tofler and other scientists at Harvard Medical School and Boston University also measured fibrinogen using an older procedure known as the Clauss Method, in which fibrinogen in a blood sample is converted to fibrin, then timed to determine how long it takes a clot to form. The FIF test, by contrast, uses an antibody, which produces a specific reaction from fibrinogen. This new method may be more adaptable for measuring fibrinogen levels in large populations.

"While our study doesn't necessarily prove that fibrinogen should be tested routinely as part of a standard physical examination, it does support the argument that measuring fibrinogen provides useful information for assessing an individual patient's risk," says Tofler.

"If I'm uncertain about what level of therapy a patient requires -- whether someone should be given a cholesterol-lowering drug, for example - finding high fibrinogen would tend to make me take a more aggressive approach in treatment," he adds. "Conversely, finding low or normal fibrinogen would reassure me."

Tofler emphasizes that it's important for the public to know that the dangers represented by high fibrinogen levels can be reduced in many cases by quitting smoking, losing weight, becoming more physically active and lowering cholesterol through dietary changes and/or medication.
This work was funded in part by the National Institutes of Health and American Biogenetic Sciences.

Co-authors are James J. Stec, B.S.; Halit Silbershatz, Ph.D.; Travis H. Matheney, MLA; Patrice Sutherland, B.S.; Izabela Lipinska, Ph.D.; Joseph M. Massaro, Ph.D.; Peter F. W. Wilson, M.D.; James E. Muller, M.D.; and Ralph B. D'Agostino, Sr., Ph.D.

NR00-1175 (Circ/Tofler)

please call: (214) 706-1396
For other information, call:
Carole Bullock: (214) 706-1279
Bridgette McNeill: (214) 706-1135

American Heart Association

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to